Harvard Bioscience, Inc.HBIONASDAQ
Loading
Direct costs attributable to producing goods sold
3Y CAGR
-8.2%/yr
vs -2.3%/yr prior
5Y CAGR
-1.6%/yr
Recent deceleration
Acceleration
-5.9pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.67M | +3.3% |
| 2024 | $39.37M | -14.7% |
| 2023 | $46.18M | -12.1% |
| 2022 | $52.52M | +2.5% |
| 2021 | $51.25M | +16.3% |
| 2020 | $44.06M | -15.0% |
| 2019 | $51.85M | -10.0% |
| 2018 | $57.59M | +6.1% |
| 2017 | $54.28M | -3.2% |
| 2016 | $56.11M | - |